Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| LYRA (Lyra Therapeutics, Inc.) | -77.27% | -94.81% | -82.86% | -72.67% | NA | NA | NA | … | … |
Data as of 06/11/2026, Common starting date is 05/04/2020
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| LYRA (Lyra Therapeutics, Inc.) | 05/04/2020 | 06/11/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | 1.45 | -94.81 | -82.86 | -72.67 | NA | NA | NA | … | … | -77.27 | -65.81 | -95.99 | 66.88 | -27.98 | -61.75 | -35.88 |
| Sharpe Ratio | NA | -0.63 | -0.47 | -0.49 | NA | NA | NA | … | … | -0.46 | -0.39 | -0.45 | 0.85 | -0.34 | -0.87 | -0.64 |
| Standard Deviation(%) | NA | 158.33 | 186.03 | 152.31 | NA | NA | NA | … | … | 213.77 | 179.56 | 220.65 | 74.73 | 87.70 | 71.22 | 76.33 |
| Draw Down(%) | NA | 98.42 | 99.88 | 99.92 | NA | NA | NA | … | … | 89.47 | 89.56 | 97.40 | 41.25 | 67.51 | 72.97 | 47.81 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/11/2026, Common starting date is 05/04/2020
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| LYRA (Lyra Therapeutics, Inc.) |
-83.04%
Mar 2023 – Mar 2026 |
-75.71%
Mar 2021 – Mar 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| LYRA (Lyra Therapeutics, Inc.) |
-18.74%
Mar 2021 – Mar 2024 |
-56.37%
Jun 2020 – Jun 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart